Clinical characteristics and treatment outcomes of gastric cancer patients with isolated para-aortic lymph node involvement

Cancer Chemotherapy and Pharmacology

Volumn 67, Issue 1, 2011, Pages 127-136

  Park, In Hae ^a   Kim, Sun Young ^a   Kim, Young Woo ^a   Ryu, Keun Won ^a   Lee, Jun Ho ^a   Lee, Jong Seok ^a   Park, Young Iee ^a   Kim, Noe Kyeong ^a   Park, Sook Ryun ^a  

^a National Cancer Center   (South Korea)

Author keywords

Advanced gastric cancer; De novo metastasis; Para aortic lymph node; Recurrent disease

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; ALBUMIN; ALKALINE PHOSPHATASE; CAPECITABINE; CISPLATIN; DOCETAXEL; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; TAXANE DERIVATIVE;

ADULT; ADVANCED CANCER; AGED; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CONTROLLED STUDY; DISTANT METASTASIS; DRUG EFFICACY; FEMALE; GASTRECTOMY; HUMAN; LEUKOCYTE COUNT; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PARAAORTIC LYMPH NODE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; STOMACH CANCER; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PALLIATIVE CARE; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL; TIME FACTORS; YOUNG ADULT;

EID: 78651073545     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-010-1296-y     Document Type: Article

References (22)

1. P Hohenberger S Gretschel 2003 Gastric cancer Lancet 362 305 315 10.1016/S0140-6736(03)13975-X 12892963 (Pubitemid 36936845)
2. HR Shin YO Ahn JM Bae MH Shin DH Lee CW Lee, et al. 2002 Cancer incidence in Korea Cancer Res Treat 34 405 408
3. M D'Angelica M Gonen MF Brennan AD Turnbull M Bains MS Karpeh 2004 Patterns of initial recurrence in completely resected gastric adenocarcinoma Ann Surg 240 808 816 10.1097/01.sla.0000143245.28656.15 15492562 (Pubitemid 39425773)
4. CH Yoo SH Noh DW Shin SH Choi JS Min 2000 Recurrence following curative resection for gastric carcinoma Br J Surg 87 236 242 1:STN:280: DC%2BD3c7jslymsQ%3D%3D 10.1046/j.1365-2168.2000.01360.x 10671934 (Pubitemid 30088655)
5. PR Patel JC Yao K Hess I Schnirer A Rashid JA Ajani 2007 Effect of timing of metastasis/disease recurrence and histologic differentiation on survival of patients with advanced gastric cancer Cancer 110 2186 2190 10.1002/cncr.23046 17896785 (Pubitemid 350100739)
6. S Takashima T Kosaka 2005 Results and controversial issues regarding a para-aortic lymph node dissection for advanced gastric cancer Surg Today 35 425 431 10.1007/s00595-004-2976-1 15912287 (Pubitemid 40873802)
7. Y Yonemura CC Wu N Fukushima I Honda E Bandou T Kawamura, et al. 2008 Randomized clinical trial of D2 and extended paraaortic lymphadenectomy in patients with gastric cancer Int J Clin Oncol 13 132 137 10.1007/s10147-007- 0727-1 18463957 (Pubitemid 351668170)
8. M Sasako T Sano S Yamamoto Y Kurokawa A Nashimoro A Kurita, et al. 2008 D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer N Engl J Med 359 453 462 1:CAS:528:DC%2BD1cXpt1Shu7Y%3D 10.1056/NEJMoa0707035 18669424
9. Y Nakane S Okamura Y Masuya S Okumura K Akehira K Hioki 1998 Incidence and prognosis of para-aortic lymph node metastasis in gastric cancer Hepatogastroenterology 45 1901 1906 1:STN:280:DyaK1M%2Fltl2jug%3D%3D 9840173
10. H Isozaki K Okajima K Fujii E Nomura N Izumi H Mabuchi, et al. 1999 Effectiveness of paraaortic lymph node dissection for advanced gastric cancer Hepatogastroenterology 46 549 554 1:STN:280:DyaK1M3ksFGntg%3D%3D 10228860
11. JH Lee YH Paik JS Lee HJ Song KW Ryu CG Kim, et al. 2006 Candidates for curative resection in advanced gastric cancer patients who had equivocal para-aortic lymph node metastasis on computed tomographic scan Ann Surg Oncol 13 1163 1167 10.1245/s10434-006-9002-3 16952027 (Pubitemid 44440416)
12. Japanese Gastric Cancer Association 1998 Japanese classification of gastric carcinoma-2nd English Edition Gastric Cancer 1 10 24 10.1007/PL00011681 11957040
13. R Kudo S Ebihara M Fujii A Kaneko S Noguchi A Uchida, et al. 2003 Classification of regional lymph nodes in Japan Int J Clin Oncol 8 248 275 10.1007/s10147-003-0343-7 (Pubitemid 37122261)
14. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92: 205-216 (Pubitemid 30099779)
15. JG Kim BY Ryoo YH Park BS Kim TY Kim YH Im, et al. 2008 Prognostic factors for survival of patients with advanced gastric cancer treated with cisplatin-based chemotherapy Cancer Chemother Pharmacol 61 301 307 1:CAS:528:DC%2BD2sXhtlWrs77E 10.1007/s00280-007-0476-x 17429626 (Pubitemid 350160328)
16. N Fuse H Fukuda Y Yamada A Sawaki W Koizumi Y Suzuki, et al. 2009 Updated results of randomized phase III study of 5-fluorouracil (5-FU) alone versus combination of irinotecan and cisplatin (CP) versus S-1 alone in advanced gastric cancer (JCOG 9912) J Clin Oncol 27 4514
17. C Pozzo Y Ohashi On behalf of the GASTRIC 2009 Meta-analyses of randomized trials assessing the influence of chemotherapy and prognostic factor in advanced/recurrent gastric cancer J Clin Oncol 27 4550
18. SS Lee JL Lee MH Ryu HM Chang TW Kim HJ Kang, et al. 2007 Combination chemotherapy with capecitabine (X) and Cisplatin (P) as first line treatment in advanced gastric cancer: experience of 223 patients with prognostic factor analysis Jpn J Clin Oncol 37 30 37 10.1093/jjco/hyl134 17272321 (Pubitemid 47096440)
19. SH Park WK Lee M Chung SM Bang EK Cho JH Lee, et al. 2006 Quality of life in patients with advanced gastric cancer treated with second-line chemotherapy Cancer Chemother Pharmacol 57 289 294 10.1007/s00280-005-0055-y 16010588
20. J Lee T Lim JE Uhm KW Park SH Park SC Lee, et al. 2007 Prognostic model to predict survival following first-line chemotherapy in patients with metastatic gastric adenocarcinoma Ann Oncol 18 886 891 1:STN:280: DC%2BD2s3ns1Klsg%3D%3D 10.1093/annonc/mdl501 17298958 (Pubitemid 47054086)
21. I Chau AR Norman D Cunningham JS Waters J Oates PJ Ross 2004 Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer-pooled analysis from three multicenter, randomized, controlled trials using individual patient data J Clin Oncol 22 2395 2403 10.1200/JCO.2004.08.154 15197201 (Pubitemid 41121931)
22. Sun J, Sun YH, Zeng ZC, Qin XY, Zeng MS, Chen B et al (2009) Consideration of the role of radiotherapy for abdominal lymph node metastases in patients with recurrent gastric cancer. Int J Radiat Oncol Biol Phys (Epub ahead)